TrialAlzheimer's research & therapy2023

Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial.

Glen Wunderlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.